Q1 2019

Source filing unavailable

Q1 2019 · —

Revenue—

Net Income

-$1.25M

N/M vs Q1 2018

EPS Diluted

-$0.19

N/M vs Q1 2018

Operating Income-$1,226,000N/M

Operating Cash Flow-$807,000—

Same quarter

Metric	Q1 2019	Q1 2018
Net Income	-$1.25M	-$254.00K
EPS Diluted	-$0.19	-$0.07

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Phathom Pharmaceuticals, Inc. · CIK 1783183 · Engraved from SEC EDGAR